#EPeeps how can we recognize,if the potential in LSPV is LAA farfield,or a signal from PV?Look at the separation of potentials during distal CS pacing! @evgeny_lyan @ThomasDemming #fellowsfirst #CardioTwitter #FOAMed

🚨New #OpenAccess Article in @JICE_EP Bipolar Radiofrequency Ablation for Refractory Scar-Related Interatrial Septal Tachycardias: a Multicenter Study 🧐📖 https://t.co/Ijx5uDCDtC by @ftrae, Łukasz Zarębski, @Dr_LohitG, Sanghamitra Mohanty, @vincenzomirco93, Prem Geeta

💊Which anti arrhythmic drug (AAD) can be responsible for this arrhythmia?💉 Don’t miss the upcoming #EHRA #Webinar: What every clinician should know about antiarrhythmic drugs 📅 9 September 2025 🕑 18:00 to 19:00 CEST 🌐 https://t.co/4oPLqvWDzY @EHRAPresident @ESC_Journals

HOTLINE 🔥in #ESCCongress2025 Personalized Digital Twin guided ablation ⬇️AFib recurrence in persistent AF! 🇰🇷 CUVIA-PRR RCT at #ESCCongress Knowledge-driven Digital Twin approach 📊 1y recurrence-free: 68% with PVI only vs 80.6% with PVI + Digital Twin

Piere Jais 🇫🇷on BEAT AF at #ESCCongress ⚡️ PFA vs 🔥 RF in paroxysmal AF 👥 292 pts, RCT, 9 EU centers 📊 No difference in AF recurrence at 12 mo ➡️ PFA is as effective as RF ablation in paroxysmal AF

🔥HOTLINE #ESCCongress ALONE Trial: OAC after AF ablation? 👥 840 pts w/o AF recurrence in 12 months randomized: OAC vs no OAC 📊 Primary endpoint (stroke, embolism, bleeding) lower in no OAC (2.2%vs 0.3 p=0.2) 🩸 Difference mainly from↓major bleeding ⚡️Ischemic events:similar

Don’t miss the Great Debates on Conduction System Pacing with Christophe Lecqlerc @NinaBecher8 @LinaMarcantoni Jens Cosedis Nilsen @HaranBurri @OCanoPerez & Fritz Prinzen 📅 08:15-09:00 📌 Damascus #ESCCongress #EHRA_ESC @EHRAPresident

Wonderful ending of day 2 in #ESC2025 with VA treatment in CMP! @GerdHindricks @KatjaZeppenfeld and @GiovanniPeretto gave us an overview of aetiology relevance and impact in therapeutical strategies in patients with NSVTs, LVCMP and inflammatory LVCMP 👏 👏 👏 @escardio

VT session at #ESCCongress chaired by @AndreaSarkozy & @Petr_Peichl @GerdHindricks on non-sustained VT in device pts: 📉 Knowledge gaps, no RCTs 📊 No ↑ mortality evidence 🫀 Evaluate structural disease 😷 Treat based on symptoms 🤝 Define & share goals with patient

#ESCCongress 🇪🇸 AI to improve management of cardiac arrhythmias 👉”Patient is not only a left atrial size” - substrate, triggers, comorbidities, biomarkers and clinical environment are crucial components that must be integrated into AI models 👉 Dynamic and multimodal ML

ECG Quiz now by the #ESCCongress! With @AndreaSarkozy @Phiso_de @BoldiKovacsMD @ManningerMartin @DrYanushiDW @simovicst @GawalkoMonika @Dominik_Linz @PriyaPBK

@purerfellner @EHRAPresident on ablation in persistent #AFib ✅ Only PVI is recommended ❓Low-voltage guided and posterior wall ablation remains area of uncertainty ❓PFA is safer, but still no hard evidence on better outcomes 🚨WITHDRAW-AF trial showing withdrawal of #HF

#ESCCongress 🇪🇸 @WFMMD presenting data from PRAETORIAN/ATLAS: Inappropriate shock with S-ICD vs. transvenous ICD 👉673 (S-ICD) vs 669 (T-ICD) patients 👉higher incidence of 1st inappropriate shock in S-ICD VS T-ICD (HR 1.61) due to cardiac oversensing or electromagnetic

VICTOR study 🤓 Vericiguat in HFrEF: no difference with placebo in reduce composite CV death or HHF @escardio #ESC75Years #CVHealthForAll #LetsRise2025 #ESCCongress @ACVCPresident @PabloJ @drdargaray @drmilicaa @RThachilMD @Hragy @HannahSchaubro1 @rafavidalperez @veramasloo

#ESC2025 alle #Youngs – kommt vorbei, nicht verpassen! 📅 30. & 31.08., ab 12 Uhr 📍 DGK-Stand Nr. 14, Halle 10 👥 Meet & Greet mit Stefan Blankenberg, @thiele_holger , Norbert Frey

3) CAAN-AF on CRT-D patients with permanent AF ➡️ AVN ablation vs drug therapy showing no difference 🚨 in HF mortality and HF events 🇦🇺 4) Analysis of PRAETORIAN and ATLAS populations on an ⬆️ of inappropriate shocks on S-ICD vs TV-ICD!! 🇨🇦🇳🇱

Outstanding Late Breaking session on advances in CIED 👏👏 1) Treebard registry showing ↗️ in CV mortality and HF hospitalization with LBBP vs RVP 🇮🇹 2) PhysioSync HF showing LBBP showing inferiority ⬇️‼️vs CRT-P in HFrEF (85% NICM) 🇧🇷 More in the thread 👇 @escardio

📢 #LateBreakingTrial @ESCCongress2025 LBBAP vs RVP in young adults – Italian registry 🇮🇹 👥 4911 screened | 344 <65y ⏱ 2-year FU ✅ LBBAP ↓ CV mortality + HF hosp. ➡️ Strongest benefit in young pts with AV block @escardio @simovicst @GawalkoMonika @PriyaPBK @Dominik_Linz

Our insights from the German National DRG Database on PVI in obese vs. non-obese pts🇩🇪#ESCCongress2025 📊 235k procedures(RF & Cryo) over 10y ⚖️ ~10%pts obese 🧑‍⚕️ Obese pts: younger, higher comorbidity burden 🏥 More ICU admissions,AKI,MACE & longer stay @evgeny_lyan @escardio

#ESCCongress 🇪🇸 👉 Future treatment options targeting the autonomic system in #AFib need deeper exploration 👉 Could PPG become the future alternative to ECG for heart rhythm monitoring? 📲 👉 Following the CARE-AF approach: start #AF management with risk factor modification!

🚨 Don’t miss! Late-Breaking Trials ⏰TODAY 16:15 📍 Hall 4 Paris ⚡ LBBAP vs RVP ⚡ Conduction system vs BiV pacing ⚡ CRT + AVN ablation (HFrEF & AF) ⚡ S-ICD vs TV-ICD shocks #ESCCongress @AriSultanEP @joselmerino @escardio @veramasloo @Dominik_Linz @simovicst @DrYanushiDW